As you may be aware a new CFTR Modulator called Trikafta, also known as triple-combination therapy, was approved in June 2021 for use in Canada.

Our clinic is working diligently to access this medication for our 375+ patients who are eligible. While we have created an FAQS list available by email bounce back at we anticipate you may have further questions so have organized a Trikafta Update: Webinar/ Q&A in the coming weeks.

We ask that you forward any questions in advance to so we may prepare for the session.


Event: Trikafta Update: Webinar/ Q&A

Date: Wednesday Dec 15, 2021

Time: 7-8:30pm (1hr presentation with an additional 30 min for further questions).

ZOOM: Please email to receive an invitation for this event.

Agenda for Trikafta Update Webinar:

  • Review who has access to Trikafta at the current time.
  • How is Trikafta accessed through public funding.
  • What process is SMH using to start patients on Trikafta.
  • Q&A

NB: This webinar will be recorded and available on our YouTube Channel in the future.

Looking forward to seeing you there.

The Toronto Adult CF Clinic